⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 8, 2024Open Access

Assessment of [18F] C05-05 PET Imaging in Participants with Parkinson's Disease in the PPMI Study (PPMI C05-05 PET Imaging) v1

View Full Paper

Ask AI

Bookmark

Share

Abstract

This protocol details the Assessment of [ 18F] C05-05 PET Imaging in Participants with Parkinson's Disease in the PPMI Study (PPMI C05-05 PET Imaging).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kenneth Marek (2024) studied this question.

synapsesocial.com/papers/68e7541bb6db6435876cbc52 https://doi.org/10.17504/protocols.io.eq2lyw3ymvx9/v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Early Longitudinal Imaging in the Parkinson’s Progression Markers Initiative Using [ 18F] AV-133 (PPMI AV-133 Prodromal Imaging) v12024 · 3 citations
2Early Longitudinal Imaging in Parkinson’s Progression Markers Initiative Using [18F] AV-133 and DaTscanTM (PPMI Early Imaging) v12024
311C-CFT PET brain imaging in Parkinson’s disease using a total-body PET/CT scanner2024 · 6 citations
4The combination of the 18F-FDG and 18F-FP-DTBZ PET for early diagnosis of cerebral glucose metabolism and dopaminergic dysfunction in Parkinson's disease2024
5Functional PET for mapping metabolic dynamics in Parkinson’s disease2025

Advances in the Use of Positronic Radiomolecular Imaging Agents in the Diagnosis of Parkinson's Disease2024
Additional Role of Midbrain F-18 FP-CIT Uptake on PET in Evaluationof Essential Tremor and Parkinsonism2023
Automated radiosynthesis and clinical experience of [18F]SMBT-1 PET imaging for in vivo evaluation of reactive astrocyte in Parkinson's disease: a pilot study2025